Literature DB >> 1330461

Systemic tumor necrosis factor-alpha production in experimental colitis.

D R Mack1, A S Lau, P M Sherman.   

Abstract

Tumor necrosis factor-alpha (TNF) is a cytokine released by mononuclear cells in response to inflammation and sepsis. Since the biological effects of TNF are consistent with the systemic and intestinal features of ulcerative colitis, the role of TNF was examined in a rabbit model of chronic colitis. Peripheral blood mononuclear cells were isolated, stimulated with lipopolysaccharide, and cultured supernatants assayed for TNF levels using a cytotoxic assay on mouse fibrosarcoma L929 cells. Basal levels of TNF production by mononuclear cells from 13 normal rabbits (124.3 units/ml +/- 27.1 units/ml, mean +/- SE) were not different from nine rabbits with colitis (83.6 units/ml +/- 24.4 units/ml, P > 0.05). Treatment with lipopolysaccharide (100 micrograms/ml) induced increased TNF production by mononuclear cells isolated from both normals (672.0 units/ml +/- 197.5 units/ml, P < 0.05) and rabbits with colitis (1114.0 units/ml +/- 489.6 units/ml, P < 0.05). However, at all lipopolysaccharide concentrations stimulated TNF levels were comparable in experimental and control groups (P > 0.05). In light of the role of leukotrienes in inflammation, a separate group of rabbits with colitis was investigated following treatment with an oral leukotriene B4 receptor antagonist. Serum TNF levels in 15 control rabbits (32.5 units/ml +/- 7.6 units/ml, mean +/- SE) were not significantly different from rabbits with colitis receiving either leukotriene B4 receptor antagonist (35.7 units/ml +/- 9.2 units/ml, N = 13) or vehicle alone (50.3 units/ml +/- 10.2 units/ml, N = 14) (ANOVA, P > 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330461     DOI: 10.1007/bf01299868

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Assays for tumour necrosis factor and related cytokines.

Authors:  A Meager; H Leung; J Woolley
Journal:  J Immunol Methods       Date:  1989-01-06       Impact factor: 2.303

2.  Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo.

Authors:  U F Schade; M Ernst; M Reinke; D T Wolter
Journal:  Biochem Biophys Res Commun       Date:  1989-03-15       Impact factor: 3.575

3.  Mucin isolated from rabbit colon inhibits in vitro binding of Escherichia coli RDEC-1.

Authors:  D R Mack; P M Sherman
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation.

Authors:  D J Fretland; S Levin; B S Tsai; S W Djurić; D L Widomski; J M Zemaitis; R L Shone; R F Bauer
Journal:  Agents Actions       Date:  1989-06

5.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

6.  A cell-mediated immune model of inflammatory bowel disease in the rabbit.

Authors:  B S Rabin; S J Rogers
Journal:  Gastroenterology       Date:  1978-07       Impact factor: 22.682

7.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

8.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

9.  An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis.

Authors:  J L Wallace; C M Keenan
Journal:  Am J Physiol       Date:  1990-04

10.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Authors:  K J Tracey; H Wei; K R Manogue; Y Fong; D G Hesse; H T Nguyen; G C Kuo; B Beutler; R S Cotran; A Cerami
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  1 in total

1.  A new chronic ulcerative colitis model produced by combined methods in rats.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.